PRESS RELEASE published on 12/04/2025 at 07:30, 2 months 18 days ago Informations privilégiées / Autres communiqués Adocia annonce une levée de fonds de 10 millions d’euros auprès de CVI Investments, Inc. pour développer ses plateformes technologiques. Nouvelle soumission d'actions et bons le 8 décembre 2025. Adocia, société de biopharma, spécialisée en diabète et obésité Biopharmaceutique Levée De Fonds Diabète ADOCIA CVI Investments
PRESS RELEASE published on 12/04/2025 at 07:01, 2 months 18 days ago Aurubis AG: High cash flow enables dividend uplift: Aurubis confirms sustainable growth strategy Aurubis AG reports high cash flow, proposes dividend increase, and confirms sustainable growth strategy for fiscal year 2024/25. Forecasting good results for 2025/26 amidst challenging market conditions Growth Strategy Cash Flow Aurubis AG Dividend Increase Forecast
REGULATED PRESS RELEASE published on 12/04/2025 at 07:01, 2 months 18 days ago bioMérieux lance deux tests pour l’endocrinologie équine : une avancée majeure pour le diagnostic et le suivi de maladies fréquentes chez les équidés bioMérieux lance deux tests pour l’endocrinologie équine, offrant des résultats précis en quelques minutes. Une avancée majeure pour le diagnostic et le suivi des maladies chez les équidés BioMérieux Diagnostic Tests Rapides Endocrinologie Équine Maladies Équines
REGULATED PRESS RELEASE published on 12/04/2025 at 07:01, 2 months 18 days ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health bioMérieux launches endocrinology testing offer for equine health with VIDAS® Equine ACTH and INSULIN immunoassays BioMérieux Veterinary Medicine Endocrinology Equine Health Immunoassay Tests
PRESS RELEASE published on 12/04/2025 at 07:00, 2 months 18 days ago Baloise Swiss Property Fund en forte croissance sur l’exercice 2024/2025 Le Baloise Swiss Property Fund affiche une croissance solide avec une performance de 23,5% et des acquisitions d'immeubles stratégiques. Focus sur la durabilité et la fusion avec Helvetia Croissance Fusion Résultat Annuel Immeubles Baloise Swiss Property Fund
PRESS RELEASE published on 12/04/2025 at 07:00, 2 months 18 days ago Swiss Re appoints Nicole Pieterse as Chief People Officer Swiss Re appoints Nicole Pieterse as Chief People Officer effective 1 January 2026, succeeding Cathy Desquesses. Board and CEO express gratitude to Cathy and welcome Nicole to advance Swiss Re's strategic people agenda Chief People Officer Swiss Re Nicole Pieterse HR Leader Strategic People Agenda
PRESS RELEASE published on 12/04/2025 at 07:00, 2 months 18 days ago INFICON announces Chief Financial Officer transition INFICON announces CFO transition as Dimitrij Lisak appointed to succeed Matthias Tröndle effective July 1, 2026 Succession Planning INFICON CFO Transition Dimitrij Lisak Matthias Tröndle
PRESS RELEASE published on 12/04/2025 at 07:00, 2 months 18 days ago Press release: Leonteq completes transition to FRTB and publishes business update Leonteq AG completes transition to FRTB and announces business update including expectations of underlying loss for 2025. CEO Christian Spieler comments on progress in client business Business Update Leonteq AG Transition FRTB Underlying Loss
PRESS RELEASE published on 12/04/2025 at 07:00, 2 months 18 days ago «Europe is on track for a cyclical rebound» Europe's economy shows signs of stabilizing with increasing government spending and positive forecasts for economic activity. Small and mid cap companies are expected to benefit from the emerging growth drivers in the region Market Analysis Economic Activity Europe Economy Small Cap Companies Fundamental Drivers
PRESS RELEASE published on 12/04/2025 at 06:59, 2 months 18 days ago ALSO strengthens financing structure with successful placement of promissory note (Schuldscheindarlehen) ALSO strengthens financing structure by successfully placing a promissory note (Schuldscheindarlehen) of EUR 250 million, leading to significant oversubscription and securing broad financial support for growth strategy Financing ALSO Holding AG Promissory Note EUR 250 Million Schuldscheindarlehen
Published on 02/21/2026 at 00:45, 1 day 21 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 21 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 22 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 23 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 12:19, 9 hours 36 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 11 hours 47 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 9 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 9 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 2 days 3 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 19:29, 2 days 2 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025